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Abstract
A prodigious number of microbes inhabit the human body, especially in the lumen of the gastrointestinal (GI) tract, yet our
knowledge of how they regulate metabolic pathways within our cells is rather limited. To investigate the role of microbiota
in host energy metabolism, we analyzed ATP levels and AMPK phosphorylation in tissues isolated from germfree and
conventionally-raised C57BL/6 mice. These experiments demonstrated that microbiota are required for energy homeostasis
in the proximal colon to a greater extent than other segments of the GI tract that also harbor high densities of bacteria. This
tissue-specific effect is consistent with colonocytes utilizing bacterially-produced butyrate as their primary energy source,
whereas most other cell types utilize glucose. However, it was surprising that glucose did not compensate for butyrate
deficiency. We measured a 3.5-fold increase in glucose uptake in germfree colonocytes. However, 13C-glucose metabolic-
flux experiments and biochemical assays demonstrated that they shifted their glucose metabolism away from mitochondrial
oxidation/CO2 production and toward increased glycolysis/lactate production, which does not yield enough ATPs to
compensate. The mechanism responsible for this metabolic shift is diminished pyruvate dehydrogenase (PDH) levels and
activity. Consistent with perturbed PDH function, the addition of butyrate, but not glucose, to germfree colonocytes ex vivo
stimulated oxidative metabolism. As a result of this energetic defect, germfree colonocytes exhibited a partial block in the
G1-to-S-phase transition that was rescued by a butyrate-fortified diet. These data reveal a mechanism by which microbiota
regulate glucose utilization to influence energy homeostasis and cell-cycle progression of mammalian host cells.
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Introduction
Metagenomics projects involving high-throughput/next-gener-
ation sequencing are being used to characterize microbial
communities within the human body [1–9], yet our knowledge
of how microbes influence biochemical and physiological processes
in the host is limited. The gastrointestinal (GI) tract harbors the
largest density of microbiota, where gut microbes outnumber all of
the somatic cells and germ cells in the human body by 10-fold
[10,11]. Furthermore, if we consider the their collective genomes,
referred to as the microbiome, the microbiota have approximately
100 times more genes than our own human genome [12]. Current
sequence data shows the gut microbiome is enriched for genes
involved in energy production and extraction [3,6,7]. For
example, carbohydrate metabolism is particularly overrepresented
with 115 families of glycoside hydrolases and 21 families of
polysaccharide lyases [3,13]. Humans lack many of these genes
presumably because mammals (and their genomes) co-evolved
with gut microbiota (and the gut microbiome) [12,14–17]. As a
result, there is a symbiotic relationship where humans and other
mammalian hosts ingest carbohydrate-rich diets and provide them
to microbiota in a protected environment; in return, the
microbiota break down the glycans into disaccharides and
monosaccharides for their own use as well as the host [18,19].
Because glycans are poorly digested by the host, microbiota are
thought to improve the ability of the host to absorb nutrients and
extract calories from their diet [18,20].
To study the function of microbiota in host metabolism,
germfree (GF) mice, which completely lack microbes, can be
compared to genetically identical mice that were raised conven-
tionally (CONV-R) with ‘‘normal’’, albeit undefined, microbiota.
Previous studies have shown that GF mice consume more food to
maintain the same body weight as CONV-R controls [21,22].
Despite this increased food intake, GF mice are leaner than
CONV-R controls and are resistant to obesity induced by a high-
fat diet [21]. They also have decreased levels of glycogen, glucose,
and insulin [21]. These findings support the idea that microbiota
increase metabolic efficiency in the host.
In a previous study, we reported that colonic tissue derived from
GF mice exhibited diminished NADH/NAD+ ratios and ATP
levels as compared to colonic tissue derived from CONV-R mice
[23]. Other tissues surveyed, however, showed no difference in
these same energetic biomarkers between GF and CONV-R mice,
thereby suggesting a selective role of microbiota in regulating
energy homeostasis in the colon. The most likely reason for this
tissue specificity is that colonocytes utilize bacterially-produced
butyrate as their primary energy source [24,25], whereas most
other cell types rely on glucose. Butyrate is a short-chain fatty acid
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(SCFA) produced by bacterial fermentation of fiber in the lumen
of the proximal colon, and we demonstrated that butyrate rescues
a severe deficit in oxidative metabolism in GF colonocytes [23].
However, we were surprised that glucose did not compensate for
the lack of butyrate in GF colonocytes because most or all cells
have the capacity to metabolize glucose. Here, in this study, we
address this issue experimentally by analyzing glucose uptake and
metabolism in GF and CONV-R colonocytes. We also demon-
strate that the perturbed metabolic state of GF colonocyte results
in a partial block in the cell-cycle as compared to CONV-R
colonocytes, and that feeding GF mice a butyrate-fortified diet
incompletely rescue this cell-cycle block in the GF colonocyte.
Results
Effect of Microbiota on Energy Homeostasis in Different
Segments of the GI Tract
We previously demonstrated that microbiota are required for
normal ATP levels in the colon but not in several other tissues that
were tested [23]. Here, we extended this analysis to different
segments of the GI tract because it is known to harbor the highest
densities of microbes in the body. In addition to the stomach, small
intestine (jejunum and ileum), proximal colon, and distal colon, we
also analyzed liver and fat (white adipose tissue) because of their
important roles in digestion and metabolism. The proximal colon,
but none of the other tissues that were tested including the distal
colon, had significantly diminished ATP levels in GF mice
compared to CONV-R controls (Figure 1A). AMPKa (59-
adenosine monophosphate-activated protein kinase a) is a
metabolic sensor activated by low ATP levels relative to AMP.
Therefore, we evaluated AMPKa activation status based on
increased Thr172 phosphorylation. As expected, we observed an
increase in AMPKa activation in the proximal colon of GF mice
relative to CONV-R but not in the distal colon or small intestine
(Figure 1B). These results extend our previous findings [23]
showing that the energetic deficit is not observed in all GI
segments, and support the idea that the proximal colon is
particularly dependent on microbiota.
GF Colonocytes Exhibit Increased Glucose Uptake and
Glycolysis
To understand the effects of microbiota on colonocyte
metabolism, we analyzed our previous transcriptome profile data
comparing freshly isolated colonocytes from CONV-R and GF
mice [23]. This analysis revealed that cell-surface transporters
were among the most highly enriched gene products upregulated
in GF colonocytes. For example, 26 members of solute carrier
(SLC) families were upregulated, whereas only 7 were downreg-
ulated (Table S1). The SLC2 family encodes facilitative (ATP-
independent) glucose transporters (GLUTs), and 3 out of 13
members were upregulated in GF (Table S1). Most GLUTs are
not expressed ubiquitously so having a subset of them affected was
expected. The SLC5A family encodes active (ATP-dependent)
glucose transporters. Members of this family are also expressed in
a tissue-restricted manner, and 2 out of 12 were upregulated in GF
including one (SLC5A1) known to function in the intestine (Table
S1). Members of other SLC families that were upregulated are
known to take up other energy substrates such as fatty acids and
amino acids (Table S1). These findings suggest that GF
colonocytes attempt to compensate for the lack of butyrate by
increasing their uptake of glucose and other alternative energy
substrates. To investigate whether the increased expression of
glucose transporters is functionally relevant and results in
increased glucose uptake, we isolated colonocytes from CONV-
R and GF mice in the presence of 6-[N-(7-nitrobenz-2-oxa-1,3-
diazol-4-yl) amino]-2-deoxy-d-glucose (6-NBDG), which is a
fluorescent glucose analog, and analyzed its uptake ex vivo.
Confocal microscopy was performed within an hour of colonocyte
isolation, and 6-NBDG levels were 3.5-fold higher inside of GF
colonocytes than CONV-R controls (Figure 2).
6-NBDG cannot be oxidized, which makes it ideal for
measuring glucose uptake but not suitable for measuring glycolysis.
To evaluate glycolysis, it was first necessary to analyze substrate
availability so we measured glucose levels in the serum of CONV-
R and GF mice. Similar to a previous finding [21], we observed a
mild hypoglycemia in GF mice compared to CONV-R controls
(Figure 3A). Next, we measured intracellular glucose, two key
intermediates of glycolysis (glucose-6-phosphate and pyruvate),
and lactate (the final end product of glycolysis) inside of
colonocytes. GF colonocytes had a ,25% decrease in intracellular
glucose, glucose-6-phosphate, and pyruvate levels compared to
CONV-R, whereas lactate levels were increased 3.5 fold
compared to CONV-R (Figure 3B–E). These results suggest that
glucose is taken up by GF colonocytes in greater quantities but it
does not accumulate because the rate of glycolysis is also increased
to an extent that yields a commensurate increase in lactate.
Glucose is Not Metabolized Oxidatively by GF
Colonocytes
When a single molecule of glucose is metabolized by glycolysis
to lactate, it yields only 2–4 ATPs; in contrast, when glucose is
converted to pyruvate followed by oxidative metabolism inside
mitochondria, it yields 36 ATPs. Considering that GF colonocytes
are in a suboptimal energetic state, it is surprising that they
metabolize glucose to lactate rather than oxidatively to CO2. To
demonstrate that oxidative metabolism is, in fact, diminished in
GF colonocytes, we performed flux experiments by adding
uniformly labeled 13C-labeled glucose to primary colonocytes as
they were being isolated from CONV-R and GF mice and then
measuring 13C-labeled CO2 using gas isotope ratio mass
spectrometry. These experiments demonstrated that in GF
colonocytes, 13C(6)-glucose is oxidized to
13CO2 at only 51% of
the normal oxidation rate that occurs in CONV-R colonocytes
(Figure 4A).
Diminished CO2 production should be coupled to diminished
oxidative phosphorylation, which we analyzed by incubating
primary colonocytes with two mitotracker probes simultaneously.
One probe fluoresced red upon being oxidized and provided a
measure of oxidative phosphorylation, while the other probe
fluoresced green regardless of mitochondrial oxidative activity and
therefore served as an internal control. As described previously
[23], GF colonocytes exhibited a marked decrease in mitochon-
drial oxidative activity (red in row 3, column 2) but showed no
difference in total mitochondria (green in row 3, column 1)
(Figure 4B). The extent to which oxidative phosphorylation was
diminished in GF colonocytes is striking because it was more
similar to sodium azide treated negative controls (red in row 2,
column 2) than CONV-R samples (red in top row, column 2).
Next, we added glucose to GF colonocytes and observed only a
modest increase in oxidative metabolic activity (red in row 4,
column 2) (Figure 4B,C). In contrast, when we added butyrate to
GF colonocytes, it stimulated such a large increase in oxidative
metabolic activity that it was comparable to CONV-R controls
(red in bottom row, column 2) (Figure 4B,C). These results
indicate that although GF colonocytes are competent to undergo
oxidative metabolism (based on the short-chain fatty acid
butyrate), they metabolize glucose primarily by glycolysis rather
than oxidatively via the TCA cycle and oxidative phosphorylation.
Microbes Regulate Host Glucose Metabolism
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PDH Inhibition Prevents Glucose from being Oxidized by
GF Colonocytes
Because butyrate stimulates oxidative activity in GF colono-
cytes, the mitochondrial enzymes involved in the TCA cycle and
electron transport chain must be functional. Therefore, the
inability of glucose to stimulate robust oxidative metabolism must
be due to an alteration specific to glucose metabolism (i.e., not
involving enzymes that also participate in butyrate metabolism).
We previously performed a proteomic analysis to identify protein
expression differences between CONV-R and GF colonoytes [23].
Further analysis of these data revealed a significant decrease in the
levels of the E1a, E1b, and E2 subunits of the pyruvate
dehydrogenase (PDH) complex in GF compared to CONV-R
colonocytes (Fig. 4D). PDH is a particularly good candidate
because it facilitates oxidative glucose metabolism by converting
cytosolic pyruvate to mitochondrial acetyl-CoA immediately
upstream of the TCA cycle [26], but is not involved in fatty acid
metabolism. Accordingly, downregulation of PDH would be
expected to result in decreased oxidative metabolism of glucose
and a concomitant rise in glycolysis (i.e., lactate production). To
validate the mass spectrometry results, we performed western blot
analyses for PDH-E1a and PDH-E1b subunits and found that
their level of expression was markedly diminished in GF
colonocytes compared to CONV-R colonocytes (Figure 4E). We
hypothesized that PDH activity would also be diminished in GF
because of increased mRNA levels of pyruvate dehydrogenase
kinase 2 (Pdk2) (based on analysis of our previous transcriptome
data [23]), which phosphorylates and inactivates the E1a
regulatory subunit [26]. To test this hypothesis, we analyzed
levels of PDH-E1a phosphorylated at Ser293. Despite total PDH-
E1a being diminished, phospho-PDH-E1a was increased
(Figure 4E). Low levels of PDH-E1a combined with the fact that
a relatively large percentage of the molecules are inactivated by
phosphorylation suggested that PDH activity should be diminished
in GF colonocytes. To test this hypothesis, we performed flux
experiments using singly-labeled glucose (13C(1)-glucose) rather
than uniformly labeled glucose (13C(6)-glucose) because the first
CO2 that is released (in this case as
13CO2) is due to PDH.
Analysis of CONV-R and GF colonocytes incubated with 13C(1)-
glucose revealed that PDH activity was diminished in GF by 94%
(Figure 4A). Taken together, these experiments provide an
explanation for why GF colonocytes undergo increased glycolysis
and decreased oxidative metabolism.
GF Colonocytes Have a Cell-Cycle Defect
The perturbed energy metabolism of GF colonocytes might be
expected to have deleterious consequences, and we previously
determined that these cells undergo increased autophagy [23].
Based on our analysis of transcriptome profiles, we also identified
decreased expression of many histone genes. The four canonical
histones (H2A, H2B, H3, and H4) are each represented by 12–17
genes arranged in 3 clusters [27]. The largest of these clusters
(Hist1) covers a large genomic interval (,2 Mbp) and contains the
majority of the core histone genes plus all 6 of the linker histone
(H1) genes. Out of 64 histone genes, 27 were downregulated in GF
while none were upregulated (Table S2). The extent of downreg-
ulation averaged 1.7 fold with a range of 1.4 to 2.1 (Table S2).
Because each of these histone genes is transcribed only during
DNA replication [28], this finding suggested that a lower
percentage of GF colonocytes are in S phase than CONV-R
colonocytes.
Figure 1. Effects of microbiota on energy metabolism biomarkers in the GI tract and digestive tissues. A, ATP levels in the stomach (S),
small intestine (SI), proximal colon (PC), distal colon (DC), liver (L), and fat (F) (white adipose tissue) of CONV-R and GF mice. Five CONV-R and five GF
mice were analyzed, and the results are mean 6 standard error. Significant differences are indicated (*p,0.05). B, Western blot analysis of AMPKa
phosphorylated at Thr172 (top panel) and total AMPKa (bottom panel) in different segments of the colon and small intestine from GF and CONV-R
mice. Results are representative of 3 independent experiments.
doi:10.1371/journal.pone.0046589.g001
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To confirm that the histone genes were serving as an accurate
marker of S phase and that GF colonocytes have a cell-cycle
defect, we performed flow cytometery to quantify the percentage
of cells in various stages of the cell cycle. Using BrdU to detect cells
in S phase and propidium iodide (PI) as a measure of DNA
content, these experiments demonstrated that GF mice have an
,80% reduction in colonocytes undergoing DNA replication in S-
phase (Figure 5A). 1.3% of GF colonocytes were in S phase
compared to 6.5% for CONV-R (Figure 5A). There was no
significant difference in the distribution of cells in early versus late
S phase suggesting DNA replication progression is not perturbed.
However, 61.5% of GF colonocytes were in G1 compared to
53.8% for CONV-R controls. The increased percentage of GF
colonocytes in G1 coupled with the decreased percentage in S
phase suggests there was a partial block in the transition from G1
to S phase. This result was consistent in three independent
experiments and suggests that the suboptimal energetic state of GF
colonocytes decreased cell-cycle progression at the G1 to S phase
transition. The GF samples also showed an increased percentage
of cells in G2 suggesting that there was also a partial block at the
G2 to M phase transition, which represents the other major cell-
cycle checkpoint.
Although the above findings demonstrate the importance of
microbiota in cell-cycle progression, they do not address whether
butyrate is a causal factor. Therefore, we provided GF mice with
an identical diet that was calorically matched except it was fortified
with tributyrin. Tributyrin is more stable than butyrate (i.e., less is
absorbed in the small intestine before it reaches the colon) and is
converted into 3 butyrate molecules in the colon. Our LC-MS/
MS analysis of luminal contents of these mice confirmed that
tributyrin was efficiently converted to butyrate in the colon based
on the concentration of tributyrin being only ,25% of butyrate
(Figure 5B). Whereas butyrate was not detectable in the colon of
GF mice provided the control diet, butyrate levels were greater
Figure 2. Microbial regulation of glucose uptake. A, 2-
deoxyglucose uptake observed as green fluorescence in CONV-R (left)
and GF (right) colonocytes counterstained with DAPI (blue). B,
Quantification of total 2-deoxyglucose fluorescence per cell in CONV-
R and GF colonocytes. Results are based on 20 cells per colonocyte
preparation from 3 independent mice and represent the mean 6 SE
with significant differences indicated (*p,0.01).
doi:10.1371/journal.pone.0046589.g002
Figure 3. Microbial regulation of glycolysis in colonocytes. A–E, Levels of serum glucose (A), intracellular glucose (B), glucose-6-phosphate
(Glu-6-P) (C), pyruvate (D), and lactate (E) in CONV-R and GF serum (A) or colonocytes (B–E). Results are mean 6 standard error from 3 independent
experiments with significant differences indicated (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0046589.g003
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than 1 mM in GF mice provided the tributyrin-containing diet.
This level was 36% of that measured in CONV-R mice
(Figure 5B). Cell-cycle analysis of GF colonocytes using BrdU
and PI showed that the tributyrin diet partially rescued the G1-to-S
phase block (Figure 5A). The percentage of cells in S phase (2.4%)
and in G1 (57.4%) was intermediate between the CONV-R and
GF samples. This rescue is consistent with our finding that
butyrate stimulates oxidative metabolism in GF colonocytes
(Figure 4B,C) and identifies butyrate as bacterial metabolite that
can promote cell-cycle progression of mammalian host cells.
Discussion
In this study we demonstrate that microbiota promote glucose
metabolism at two levels. At a systemic level, microbiota increase
blood glucose levels since GF mice are mildly hypoglycemic, which
is consistent with a previous report [21]. This is consistent with the
idea that the gut microbiome is highly enriched for genes encoding
glycoside hydrolases and polysaccharide lyases that convert
glycans into simple sugars that are absorbed in the small intestine.
At a local level, microbiota also influence how glucose is utilized by
colonocytes, and this is presented as a model in Figure 6. Based on
comparisons between CONV-R and GF colonocytes, microbes
promote oxidative metabolism by increasing PDH levels and
enzymatic activity to direct glucose-derived carbon into the TCA
cycle. This is apparent from the results of our experiments showing
that GF colonocytes take up increased levels of glucose but shift
away from oxidative metabolism/CO2 production and towards
glycolysis and lactate production. Although this metabolic shift
apparently does not occur in GF liver [28], it might occur in other
GF tissues since GF mice consume less oxygen than CONV-R
controls [21]. The increased glucose uptake in GF colonocytes
presumably represents an attempt to compensate for the loss of
their preferred energy substrate, which is bacterial-produced
butyrate. However, the downregulation of PDH and shift to
glycolysis does not yield enough ATPs to compensate. Unlike
tumor cells undergoing the Warburg effect, it is not clear how this
shift to glycolysis would be advantageous to GF colonocytes.
Considering that ATP levels of GF colonocytes are approximately
half of CONV-R controls, this shift from oxidative metabolism to
Figure 4. Microbes and butyrate stimulate oxidative metabolism. A, Levels of free 13CO2 released from CONV-R and GF colonocytes
following their incubation with uniformly labeled (13C(6)) or singly labeled (
13C(1)) glucose.
13CO2 levels were detected by isotope-ratio mass
spectrometry, and the results are presented as mean 6 standard error from 3 independent experiments with significant differences indicated
(*p,0.01). B, Oxidative metabolism indicated by MitoTracker Red CM-H2XRos (red fluorescence; second column) and total mitochondria indicated by
the non-oxidizable MitoTracker Green FM (green fluorescence; first column) in colonocytes from CONV-R (top two rows) and GF (bottom three rows).
The sodium azide treated cells in the second row serve as a negative control. The effect of glucose and butyrate on GF colonocytes in the two bottom
rows is compared to untreated GF colonocytes in the row immediately above. C, Quantification of oxidative metabolism in the different experimental
groups. Determined as the ratio of red fluorescence relative to green fluorescence (internal control). Results are based on 20 cells per condition from
3 independent experiments and represent the mean 6 SE with significant differences indicated (*p,0.01). D, Spectral counts from quantitative mass
spectrometry of pyruvate dehydrogenase subunits in CONV-R and GF colonocytes. E, Western blot analysis of the E1a and E1b subunits of PDF from
CONV-R and GF colons with b–actin serving as a loading control. Results are representative of 3 independent experiments. F, Western blot analysis of
phospho-PDH (E1a) and total PDH (E1a) from CONV-R and GF colons. Results are representative of 3 independent experiments.
doi:10.1371/journal.pone.0046589.g004
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glycolysis might be viewed as a pathological condition that
prevents increased glucose uptake from compensating. The
mammalian genome co-evolved with the gut microbiome so it is
not surprising that metabolic defects arise in the GF condition.
The decreased ATP levels in GF colonocytes leads to AMPK
activation as shown here and autophagy as shown previously [23].
One might expect decreased ATP levels to result in additional
deleterious consequences, and here we demonstrate that cell-cycle
progression is diminished at the transition from G1 to S phase. One
possibility is that a nutrient sensing pathway, possibly involving
AMPK, regulates the restriction point of the cell cycle. However,
other possibilities cannot be excluded. For example, we did not
observe energy homeostasis perturbations in the GF small intestine,
yet this tissue also shows diminished cell proliferation based on
previous studies that measured [3H]-thymidine incorporation in GF
samples compared to CONV controls [29,30]. However, in our
experiments, we know that butyrate is a causal factor because
providing GF mice with tributyrin partially rescued the G1-to-S
phase block. Because butyrate is the preferred energy source of
colonocytes, our work supports the idea that the cell-cycle defect in
GF colonocytes arises because of suboptimal energy metabolism.
Materials and Methods
Ethics Statement and mice
All mouse experiments were approved by the Institutional
Animal Care and Use Comittees (IACUC) review board at the
University of North Carolina as approved protocol ID # 10-186
and were performed in accordance with federal guidelines. Eight-
to fourteen-week-old CONV-R or GF male C57BL/6 mice were
used in all experiments, with the exception of ATP experiments,
which used BALB/c mice. Conventionally-raised mice were
reared in a specific pathogen-free (SPF) facility, while germfree
mice were maintained in a gnotobiotic facility. Light/dark cycles
and animal husbandry practices were identical between the
facilities except that aseptic technique was performed in the
gnotobiotic facility. For the flow cytometry experiments, the
tributyrin-fortified (5AVC) and control (5SRZ) diets were from
Test Diet (Richmond, IN).
Isolation of Colonocytes
Colonic epithelial cells were isolated according to [31] in order
to exclude cell types other than colonocytes such as immune cells,
smooth muscle, and enteric neurons. Briefly, animals were
euthanized by CO2 asphyxiation followed by cervical dislocation.
Proximal colons were dissected, flushed with sterile Phosphate-
buffered Saline (PBS), and splayed open longitudinally along
Whatmann paper. The colon was then washed 3 more times in
PBS, pealed from paper, and placed in PBS solution containing
5 mM EDTA. Submerged colon was then incubated on a rotator
for 30 minutes at 37uC. After 30 minutes, colonic tissue was
removed leaving isolated colonocytes, which were washed twice
with PBS, and used for experiments.
Figure 5. Microbes and butyrate promote cell-cycle progression at the G1-to-S phase transition. A, Flow cytometry profiles of
colonocytes from CONV-R mice (left), GF mice (center), and GF mice provided a tributyrin-fortified diet (right). PI levels are shown on the x-axis, and
BrdU incorporation is shown on the y-axis. The percentage of cells in various stages of the cell cycle are indicated: P1, G1; P2, early S; P3, middle S; P4,
late S; P5, G2. Results are representative of 3 independent experiments. B, Measurements of luminal butyrate (left) and tributyrin (right) levels from
the colon of CONV-R mice and GF mice provided either a provided a control diet (GF) or a tributyrin-fortified diet (GF + Tributyrin). Results are mean
6 standard error from 3 independent experiments with significant differences indicated (*p,0.01). N.D., not detectable.
doi:10.1371/journal.pone.0046589.g005
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Western Blot
Cells or tissues were flash-frozen and homogenized or agitated
in 8.3 M urea lysis buffer with NaF and Na orthovanadate and
incubated on wet ice for 30 minutes. Samples were then
centrifuged at 14,000 rpm for 20 minutes at 4uC. Protein
supernatant was transferred to a new 1.5 mL eppendorf tube
and protein concentration was determined by Bradford assay.
Protein homogenates were separated on 10, 12, and 4–20%
gradient SDS-polyacrylamide gels and transferred onto PVDF
membrane. Membranes were then incubated on rocker in 3%
BSA or 5% non-fat dry milk with NaF for 1 hr at RT. Blocked
membranes were incubated in 1uAb overnight on rotator at 4uC.
Antibodies were used at 1:250 to 1:2000 and included AMPKa
(Cell Signaling, Danvers, MA), phospho-AMPKa (Cell Signaling),
pyruvate dehydrogenase cocktail (Mitosciences, Eugene, OR;
MSP02), phospho-PDH-E1a (Abcam; ab92696), and b-actin
(Abcam; ab8226). Blots were washed 3X for 10 min/wash in 1X
TBST or 1X PBST (for non-phospho Westerns) at RT and
incubated with horseradish peroxidase-conjugated secondary
antibodies (1:2000 to 1:4000) for 1 hr and 30 min on rocker at
room temperature. Membranes were then washed 3 additional
times in 1XTBST or 1XPBST (for non-phospho Westerns),
treated with ECL reagent, and developed for analysis.
Metabolic Assays
All metabolic assays were performed with Biovision (Mountain
View, CA) metabolism kits. Specifically, ATP (K354-100), glucose
(K606-100), glucose-6-phosphate (K657-100), pyruvate (K609-
100), and lactate (K607-100) were used in accordance to
manufacturer specifications. For all assays, flash-frozen tissue
was deproteinized with Perchloric acid kit (K808-200), which was
also from Biovision. Results represent 4–6 independent biological
replicates.
Fluorescence Microscopy
The reagents 6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-
2-deoxy-d-glucose (6-NBDG), MitoTracker Red CM-H2XRos,
and MitoTracker Green FM were purchased from Invitrogen
(Carlsbad, CA). For 6-NDBG uptake assessment, 1 mM 6-NDBG
was added to PBS/EDTA solution while isolating colonocytes (see
Figure 6. A model of microbial regulation of glucose metabolism in host colonocytes. Microbes increase blood glucose levels and increase
PDH levels and activity to facilitate oxidative metabolism of glucose in the mitochondria. In contrast, GF mice are hypoglycemic, and their
colonocytes respond by increased expression of GLUTs. Although this leads to increased glucose uptake, Glu-6-P and pyruvate levels are diminished
because of their conversion to lactate, which is increased in GF colonocytes. This increase in glycolysis can be attributed to decreased PDH
expression/activity and decreased oxidative metabolism in the mitochondria. Not only are PDH levels decreased, but also enzymatic activity is
inhibited via phosphorylation of the E1a regulatory subunit due to increased expression of PDK2 in GF colonocytes.
doi:10.1371/journal.pone.0046589.g006
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above). Colonocytes were stained with DAPI and mounted on
slides with coverslip. Cells were viewed with Olympus IX81
microcope equipped with FITC, Texas Red, Rhodamine, and
DAPI filters. All fluorescent micrographs were acquired with the
same exposure and focal plane. Image J (Bethesda, MD) was used
to quantify integrated density (total fluorescence) per cell.
In a manner similar to the 6-NDBG, mitotracker dyes were
added at 500 nM (MitoTracker Red CM-H2XRos), and 500 nM
(MitoTracker Green FM) while isolating colonocytes. Image J was
used to analyze mean fluorescence for both mitotracker dyes. The
red-to-green fluorescence is an indication of oxidative metabolism
in the colonocytes. All micrographs were taken with identical
exposures. Z-stacks were acquired for each image and for each cell
the individual z-stacks did not differ in red-to-green mean
fluorescence between focal planes. For both 6-NDBG and
mitotracker experiments, we used 3 independent biological
replicates per experimental group.
Liquid Chromatography - Mass Spectrometry
GF mice were given a tributyrin-fortified diet over a two-week
period, Endogenous butyrate and tributyrin were measured from
luminal contents of CONV-R and GF mice. An internal 13C1-
butyrate standard was added, and luminal contents were
resuspended in 0.1% ammonium hydroxide. Proteins were
removed by centrifugation through 3-kDa spin-filters. Flow
through was then analyzed for butyrate or tributyrin content by
HPLC separation with subsequent detection by an Agilent 6520
AccurateMass Q-TOF mass spectrometer operating in negative
mode (Santa Clara, CA). Peak areas were calculated using
MassHunter Workstation software. Chromatographic peaks were
integrated for samples and areas were compared to peak area for
standards (10 mM) for each compound.
Isotope Ratio Mass Spectrometry
The amount of 13CO2 in Exetainer breath storage tubes
generated from colonocytes was measured with a Europa Scientific
20/20 gas isotope ratio mass spectrometer (Europa Scientific,
Cincinnati, OH). Dissolved CO2 in solution was liberated to the
tube headspace by addition of 100 mL saturated citric acid. The
ratio of 13CO2 to
12CO2 (mass 45 to 44) was measured directly
from the sample tube headspace. All samples were compared to an
internal reference gas (5% CO2, balance 75% N2, 20% O2) that
had been calibrated against the international standard PeeDee-
Belmnite (PDB). Changes in 13CO2 enrichment before and after
glucose administration were calculated. CO2 standards at three
different 13C enrichments were run before and after the run to
check instrument performance. The analytical precision of the
instrument is 0.0001 atom % 13C.
Flow Cytometry
Mice received i.p. injections of BrdU (50 mg/kg body weight)
and colonocytes were prepared (as described above) 2 hours later.
Following wash steps, 26106 colonocytes in 1 mL of PBS were
fixed by the addition of 3 mL of ice-cold ethanol. This was done
dropwise while vortexing. Following fixation, 1 mL of 50 mg/mL
propidium iodide and 50 mL of 10 mg/mL of RNAse A was
added and incubated at 4uC for 3 hours. For flow cytometry,
mouse anti-BrdU followed by goat-anti-mouse IgG FITC incuba-
tion/wash steps were followed by flow cytometry following
standard procedures.
Statistics
For all metabolic assays and image quantification (mitotracker
and 6-NDBG experiments) significant differences between exper-
imental groups were determined by two-tail t-test (p,0.05). All
data are expressed as mean 6 SEM.
Supporting Information
Table S1 SLC Gene Expression Changes in GF Colonocytes.
Data are derived from a transcriptome analysis from CONV-R
and GF colonocytes.
(PDF)
Table S2 Histone Gene Expression Changes in GF Colonocytes.
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